» Authors » Gaby Sroczynski

Gaby Sroczynski

Explore the profile of Gaby Sroczynski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 637
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jahn B, Bundo M, Arvandi M, Schaffner M, Todorovic J, Sroczynski G, et al.
BMC Gastroenterol . 2025 Mar; 25(1):170. PMID: 40082770
Background: White light (conventional) colonoscopy (WLC) is widely used for colorectal cancer screening, diagnosis and surveillance but endoscopists may fail to detect adenomas. Our goal was to assess and synthesize...
2.
Foremnik K, Sroczynski G, Stratil J, Neumann A, Buchberger B
PLoS One . 2025 Mar; 20(3):e0318792. PMID: 40063892
Purpose: Children and adolescents experiencing psychiatric crises often undergo inpatient treatment, which may limit family involvement, stigmatize young individuals, and impede the application of therapeutic outcomes in their daily lives....
3.
Rietjens J, Griffioen I, Sierra-Perez J, Sroczynski G, Siebert U, Buyx A, et al.
Palliat Care Soc Pract . 2024 Feb; 18:26323524231225249. PMID: 38352191
Background: Patients with cancer often have to make complex decisions about treatment, with the options varying in risk profiles and effects on survival and quality of life. Moreover, inefficient care...
4.
Crispin A, Rehms R, Hoffmann S, Lindoerfer D, Hallsson L, Jahn B, et al.
Dtsch Arztebl Int . 2023 Oct; 120(46):786-792. PMID: 37855423
Background: Persons with a positive family history of colorectal cancer (CRC) are more likely than others to develop CRC and are also younger at the onset of the disease. Nonetheless,...
5.
Sroczynski G, Hallsson L, Muhlberger N, Jahn B, Rehms R, Hoffmann S, et al.
Int J Cancer . 2023 Oct; 154(3):516-529. PMID: 37795630
Individuals with a family history of colorectal cancer (CRC) may benefit from early screening with colonoscopy or immunologic fecal occult blood testing (iFOBT). We systematically evaluated the benefit-harm trade-offs of...
6.
Sturzlinger H, Conrads-Frank A, Eisenmann A, Invansits S, Jahn B, Janzic A, et al.
Ger Med Sci . 2023 Jul; 21:Doc06. PMID: 37426885
Background: Stool DNA testing for early detection of colorectal cancer (CRC) is a non-invasive technology with the potential to supplement established CRC screening tests. The aim of this health technology...
7.
Hallsson L, Sroczynski G, Engel J, Siebert U
BMC Cancer . 2023 Jun; 23(1):590. PMID: 37365514
Background: Women with inherited mutations in the BRCA1 or BRCA2 genes have increased lifetime risks for developing breast and/or ovarian cancer and may develop these cancers around the age of...
8.
Kuhne F, Schomaker M, Stojkov I, Jahn B, Conrads-Frank A, Siebert S, et al.
Ger Med Sci . 2023 Feb; 20:Doc12. PMID: 36742460
Objectives: Public health decision making is a complex process based on thorough and comprehensive health technology assessments involving the comparison of different strategies, values and tradeoffs under uncertainty. This process...
9.
Herzog C, Sundstrom K, Jones A, Evans I, Barrett J, Wang J, et al.
Clin Epigenetics . 2022 Nov; 14(1):150. PMID: 36414968
Background: Cervical screening using primary human papilloma virus (HPV) testing and cytology is being implemented in several countries. Cytology as triage for colposcopy referral suffers from several shortcomings. HPV testing...
10.
Bicher M, Rippinger C, Zechmeister M, Jahn B, Sroczynski G, Muhlberger N, et al.
PLoS One . 2022 May; 17(5):e0265957. PMID: 35499997
Background And Objective: The distribution of the newly developed vaccines presents a great challenge in the ongoing SARS-CoV-2 pandemic. Policy makers must decide which subgroups should be vaccinated first to...